시장보고서
상품코드
1962108

수술 중 신경 모니터링 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

Global Intraoperative Neuromonitoring Market Size, Share, Trends & Growth Analysis Report 2026-2034

발행일: | 리서치사: Value Market Research | 페이지 정보: 영문 189 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

수술 중 신경 모니터링 시장 규모는 2025년 64억 3,000만 달러에서 2026년부터 2034년까지 CAGR 6.72%로 성장하여 2034년에는 115억 5,000만 달러에 달할 것으로 예측됩니다.

수술 중 신경 모니터링(IONM) 시장은 수술 중 환자 안전에 대한 수요 증가와 신경 모니터링 기술의 발전으로 인해 괄목할 만한 성장세를 보이고 있습니다. IONM은 척추, 뇌, 말초신경과 관련된 복잡한 수술에서 신경학적 손상의 위험을 최소화하는데 매우 중요한 역할을 하고 있습니다. 의료진이 환자의 치료 결과를 우선시하는 가운데, IONM의 도입은 점점 더 보편화되고 있으며, 외과의사와 마취과 의사는 수술 중 정보에 입각한 판단을 내리기 위해 실시간 데이터에 의존하고 있습니다. 근전도(EMG), 뇌파(EEG), 체성감각유발전위(SSEP) 등 모니터링 기술의 혁신은 신경 모니터링의 정확성과 신뢰성을 높여 시장 성장을 더욱 촉진하고 있습니다.

또한, 신경 질환의 유병률 증가와 수술 건수 증가가 수술 중 신경 모니터링 서비스 수요를 견인하고 있습니다. 인구 고령화와 함께 종양, 척추 질환, 간질 등의 질병 발생률이 증가함에 따라 효과적인 신경 모니터링 솔루션의 필요성이 점점 더 중요해지고 있습니다. 또한, 최소침습 수술 기술의 중요성이 높아지는 것도 IONM 시장 확대에 기여하고 있습니다. 이러한 수술은 환자의 안전과 최적의 결과를 보장하기 위해 고도의 모니터링이 필요한 경우가 많기 때문입니다.

또한, 인공지능과 머신러닝과 같은 첨단 기술의 통합은 IONM의 분야를 변화시키고 있습니다. 이러한 기술을 통해 더 높은 수준의 데이터 분석과 예측 모델링이 가능해져 수술 중 위험 평가와 의사결정을 개선할 수 있게 되었습니다. 원격의료 및 원격 모니터링 기능의 부상도 IONM 서비스에 대한 접근을 촉진하고 있으며, 의료 제공자가 실시간으로 전문적인 상담 및 지원을 제공할 수 있도록 하고 있습니다. 요약하면, 수술 중 신경 모니터링 시장은 기술 발전, 환자 안전에 대한 관심, 수술 결과 개선에 대한 노력으로 인해 견조한 성장이 예상됩니다.

목차

제1장 소개

제2장 주요 요약

제3장 시장 변수, 동향, 프레임워크

제4장 세계의 수술 중 신경 모니터링 시장 : 제품 및 서비스별

제5장 세계의 수술 중 신경 모니터링 시장 : 소스 유형별

제6장 세계의 수술 중 신경 모니터링 시장 : 용도별

제7장 세계의 수술 중 신경 모니터링 시장 : 모달리티별

제8장 세계의 수술 중 신경 모니터링 시장 : 최종사용자별

제9장 세계의 수술 중 신경 모니터링 시장 : 지역별

제10장 경쟁 구도

제11장 기업 개요

KSM 26.03.20

The Intraoperative Neuromonitoring Market size is expected to reach USD 11.55 Billion in 2034 from USD 6.43 Billion (2025) growing at a CAGR of 6.72% during 2026-2034.

The intraoperative neuromonitoring (IONM) market is experiencing significant growth, driven by the increasing demand for patient safety during surgical procedures and advancements in neuromonitoring technologies. IONM plays a crucial role in minimizing the risk of neurological damage during surgeries, particularly in complex procedures involving the spine, brain, and peripheral nerves. As healthcare providers prioritize patient outcomes, the adoption of IONM is becoming more prevalent, with surgeons and anesthesiologists relying on real-time data to make informed decisions during operations. Innovations in monitoring techniques, such as electromyography (EMG), electroencephalography (EEG), and somatosensory evoked potentials (SSEPs), are enhancing the accuracy and reliability of neuromonitoring, further driving market growth.

Moreover, the increasing prevalence of neurological disorders and the rising number of surgical procedures are propelling the demand for intraoperative neuromonitoring services. As the population ages and the incidence of conditions such as tumors, spinal disorders, and epilepsy rises, the need for effective neuromonitoring solutions becomes more critical. Additionally, the growing emphasis on minimally invasive surgical techniques is contributing to the expansion of the IONM market, as these procedures often require enhanced monitoring to ensure patient safety and optimal outcomes.

Furthermore, the integration of advanced technologies, such as artificial intelligence and machine learning, is transforming the IONM landscape. These technologies enable more sophisticated data analysis and predictive modeling, allowing for improved risk assessment and decision-making during surgeries. The rise of telemedicine and remote monitoring capabilities is also facilitating access to IONM services, enabling healthcare providers to offer expert consultations and support in real-time. In summary, the intraoperative neuromonitoring market is set for robust growth, characterized by technological advancements, a focus on patient safety, and a commitment to improving surgical outcomes.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Products and Services

  • Systems
  • Accessories
  • Services

By Source Type

  • Insourced Monitoring
  • Outsourced Monitoring

By Application

  • Spinal Surgery
  • Neurosurgery
  • Orthopedic Surgery
  • ENT Surgery
  • Vascular Surgery
  • Other

By Modality

  • Motor evoked potentials (MEPs)
  • Somatosensory evoked potentials (SSEPs)
  • Electroencephalography (EEG)
  • Electromyography (EMG)
  • Brainstem auditory evoked potentials (BAEPs)
  • Visual evoked potentials (VEPs)

By End User

  • Hospitals
  • Ambulatory Surgical Centers (ASCs)

COMPANIES PROFILED

  • Nihon Kohden Corporation, NeuroStyle PteLtd, SpecialtyCare, Intranerve Neuroscience Holdings, LLC, inomed Medizintechnik GmbH, Medtronic plc, Natus Medical Incorporated, NuVasive, Inc, Accurate Monitoring, Computational Diagnostics, Inc

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET: BY PRODUCTS AND SERVICES 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Products And Services
  • 4.2. Systems Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Accessories Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET: BY SOURCE TYPE 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Source Type
  • 5.2. Insourced Monitoring Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Outsourced Monitoring Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET: BY APPLICATION 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast Application
  • 6.2. Spinal Surgery Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Neurosurgery Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Orthopedic Surgery Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.5. ENT Surgery Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.6. Vascular Surgery Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.7. Other Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET: BY MODALITY 2022-2034 (USD MN)

  • 7.1. Market Analysis, Insights and Forecast Modality
  • 7.2. Motor evoked potentials (MEPs) Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.3. Somatosensory evoked potentials (SSEPs) Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.4. Electroencephalography (EEG) Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.5. Electromyography (EMG) Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.6. Brainstem auditory evoked potentials (BAEPs) Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.7. Visual evoked potentials (VEPs) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET: BY END USER 2022-2034 (USD MN)

  • 8.1. Market Analysis, Insights and Forecast End User
  • 8.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 8.3. Ambulatory Surgical Centers (ASCs) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET: BY REGION 2022-2034(USD MN)

  • 9.1. Regional Outlook
  • 9.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.2.1 By Products And Services
    • 9.2.2 By Source Type
    • 9.2.3 By Application
    • 9.2.4 By Modality
    • 9.2.5 By End User
    • 9.2.6 United States
    • 9.2.7 Canada
    • 9.2.8 Mexico
  • 9.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.3.1 By Products And Services
    • 9.3.2 By Source Type
    • 9.3.3 By Application
    • 9.3.4 By Modality
    • 9.3.5 By End User
    • 9.3.6 United Kingdom
    • 9.3.7 France
    • 9.3.8 Germany
    • 9.3.9 Italy
    • 9.3.10 Russia
    • 9.3.11 Rest Of Europe
  • 9.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.4.1 By Products And Services
    • 9.4.2 By Source Type
    • 9.4.3 By Application
    • 9.4.4 By Modality
    • 9.4.5 By End User
    • 9.4.6 India
    • 9.4.7 Japan
    • 9.4.8 South Korea
    • 9.4.9 Australia
    • 9.4.10 South East Asia
    • 9.4.11 Rest Of Asia Pacific
  • 9.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.5.1 By Products And Services
    • 9.5.2 By Source Type
    • 9.5.3 By Application
    • 9.5.4 By Modality
    • 9.5.5 By End User
    • 9.5.6 Brazil
    • 9.5.7 Argentina
    • 9.5.8 Peru
    • 9.5.9 Chile
    • 9.5.10 South East Asia
    • 9.5.11 Rest of Latin America
  • 9.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.6.1 By Products And Services
    • 9.6.2 By Source Type
    • 9.6.3 By Application
    • 9.6.4 By Modality
    • 9.6.5 By End User
    • 9.6.6 Saudi Arabia
    • 9.6.7 UAE
    • 9.6.8 Israel
    • 9.6.9 South Africa
    • 9.6.10 Rest of the Middle East And Africa

Chapter 10. COMPETITIVE LANDSCAPE

  • 10.1. Recent Developments
  • 10.2. Company Categorization
  • 10.3. Supply Chain & Channel Partners (based on availability)
  • 10.4. Market Share & Positioning Analysis (based on availability)
  • 10.5. Vendor Landscape (based on availability)
  • 10.6. Strategy Mapping

Chapter 11. COMPANY PROFILES OF GLOBAL INTRAOPERATIVE NEUROMONITORING INDUSTRY

  • 11.1. Top Companies Market Share Analysis
  • 11.2. Company Profiles
    • 11.2.1 Nihon Kohden Corporation
    • 11.2.2 NeuroStyle Pte.Ltd
    • 11.2.3 SpecialtyCare
    • 11.2.4 Intranerve Neuroscience Holdings, LLC
    • 11.2.5 Inomed Medizintechnik GmbH
    • 11.2.6 Medtronic Plc
    • 11.2.7 Natus Medical Incorporated
    • 11.2.8 NuVasiveInc
    • 11.2.9 Accurate Monitoring
    • 11.2.10 Computational DiagnosticsInc
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제